FDA Investigator Babajide Michael Osunsanmi
Babajide Michael Osunsanmi has conducted inspections on 38 sites in 1 countries as of 29 Nov 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
38
Last Inspection Date:
29 Nov 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Babajide Michael Osunsanmi:
Abby M Miller,
Ademola O Daramola,
Alan L Truong,
Alan P Kurtzberg,
Albert C Cheng,
Alexandra B Pitkin,
Allison A Rodriguez,
Amalia C Himaya,
Amir Alavi,
Angelina M Albert,
Anita Narula, PhD,
April P Shaw,
Arsen Karapetyan,
Barbara J Rincon,
Belinda E Clifton,
Binh T Nguyen,
Brian J Ryan,
Brian P Putz,
Brien C Fox,
Bryan A Galvez,
Bryce A Hammer,
Bush,
Candace Y Gomez Broughton,
Carla J Lundi,
Carol B Czerniak,
Caryn M Everly,
Caryn M Mcnab,
Cathleen A Carr Sharpe,
Cecilia H Kieu,
Celena Ngo,
Chelsea N Sealey,
Crystal Monroy,
Darren S Brown,
David G Whitman,
David Y Hernandez,
Davis,
Deborah A Greco,
Deborah G Park,
Dejon N Harris,
Diane Cvan Leeuwen,
Doan T Nguyen, PharmD,
Donna Ltartaglino Besone,
Donna Mwilliams Hill, PhD,
Dyana K Stone,
Esther B Gamallo Herrera,
Garciam,
Gavin T Cua,
Geraldine M Peregrin,
Grace P Santos,
Greg K Keshishyan,
Henry E Carrillo,
Jacob W Reynolds,
Jacobitz,
Jacqueline C Sram,
James A Barreto,
Jane S Wernberg,
Jasmine N Thompson,
Jeff M Uriarte,
Jeffery A Johnson,
Jeffrey P Raimondi,
Jennifer M Gogley,
Jeremy Beber,
Jeremy H Nguyen,
Joel D Hustedt,
Joey V Quitania,
John A Gonzalez,
John A Liu,
John P Jorgensen,
Jolanna A Norton,
Joseph C Yen,
Judy C Nepsa,
Julie A Rorberg,
Julie A Stocklin,
Ka L Wong,
Katherine E Jacobitz,
Kawshalya Pathiraja,
Kelley,
Kevin Lee,
Kham Phommachanh,
Khoa Nathanv Tran,
Kim Lthomas Cruse,
Kirtida Patel,
Lanita F Kelley,
Leonard H Lavi,
Linda Thai,
Ling Yu L Liu,
Lisa Shin,
Louis B Cencetti,
Marco S Esteves,
Marcus F Yambot,
Mark C Saale,
Matthew J Johnson,
Michael D Garcia,
Michael F Schuette,
Michael S Call,
Michael Shanks, MS,
Minh D Phan,
Myers,
Nancy E Byerly,
Natalie J Ayoub,
Nianna C Burns,
Nicholas L Hunt,
Patricia F Alberico,
Paul A Bonneau,
Paul R Whitby,
Phal K Chhun,
Phillip L Toy,
Rachel C Stanton,
Richard C Chiang,
Richard W Tubb,
Richmond K Yip,
Robert C Hoover,
Rochelle A Rolnik,
Rocio Guzman Velazquez,
Rowena S Nguyen,
Rumany C Penn, PharmD,
Saied A Asbagh,
Santiago Gallardo Johnson,
Scott J Matsuda,
Sean P Desbrow,
Selene T Torres,
Sharon S Ho,
Sonia R Peterson,
Sonya L Karsik, RAC,
Sparky L Bartee,
Stephanie A Slater, MS,
Sundy V Sedwick,
Taichun Qin, PhD,
Tamala P Bogan,
Tamala P Magee,
Tamara L Ely,
Tammy Vasquez Hancock,
Tara L Stockton,
Terrance P Nguyen,
Terri L Dodds,
Thao T Kwan,
Theresa Kirkham (NMI),
Thomas J Arista,
Thomas R Beilke,
Thuy T Nguyen, LCDR,
Tracey T Duong,
Truong Xuan Nguyen (Andy),
Uttaniti Limchumroon (Tom),
Vashti E Bocker,
Vickie L Anderson,
Virgilio F Pacio, CSO,
William D Boden,
Yasamin Ameri,
Yvette Mlacour Davis,
Yvonne T Lacour,
Zachary A Bogorad,
Zachary L Miller
Babajide Michael Osunsanmi's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2010 | FDA 483 | PRESTIGE COSMETICS, INC. - Form 483, 2010-03-24 |
February, 2010 | FDA 483 | MeriCal, Inc - Form 483, 2010-02-10 |
August, 2010 | FDA 483 | Beauty Health & Science Innovations Inc - Form 483, 2010-08-25 |
February, 2011 | FDA 483 | Private Label Partners, Inc. - Form 483, 2011-02-10 |
December, 2009 | FDA 483 | Preferred Pharmaceuticals Inc. - Form 483, 2009-12-30 |
April, 2010 | FDA 483 | 220 Laboratories LLC. - Form 483, 2010-04-26 |
June, 2009 | FDA 483 | Thibiant International, Inc. - Form 483, 2009-06-25 |
May, 2010 | FDA 483 | Old Fashioned Natural Products Inc - Form 483, 2010-05-27 |
January, 2010 | FDA 483 | GMP Laboratories of America Inc - Form 483, 2010-01-20 |
July, 2009 | FDA 483 | Pacira Pharmaceuticals, Inc. - Form 483, 2009-07-10 |
August, 2010 | FDA 483 | Almil Nutritional Products, Inc. - Form 483, 2010-08-09 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more